In Vitro Antibacterial Effectiveness of Stingless Bee Propolis against Infected Breast Cancer Ulcer
DOI:
https://doi.org/10.35790/ecl.v14i1.65682Keywords:
breast cancer; ulcer; stingless bee; propolis; antibacterial effectAbstract
Abstract: Breast cancer is the most common cancer in women and often presents with malignant ulcers prone to infection. These wounds are difficult to manage, especially during chemotherapy, due to polymicrobial colonization and rising antibiotic resistance. Stingless bee propolis, rich in bioactive flavonoids, has shown promising antibacterial properties. This study aimed to evaluate in vitro antibacterial effectiveness of stingless bee propolis against bacteria from breast cancer ulcers. This was an in vitro study conducted at the Poltekkes Kemenkes Manado Medical Laboratory (July 2024–January 2025). Methanol-extracted stingless bee propolis was tested against MRSA and P. aeruginosa using disc diffusion, MIC, and MBC methods. Antibacterial activity was evaluated through inhibition zones and bacterial growth in serial dilutions. The outcomes were analyzed based on inhibition zone diameters and bacterial growth in serial dilutions. The results showed that propolis extract demonstrated antibacterial activity against MRSA and P. aeruginosa, with inhibition zones observed in both disc diffusion and dilution methods. Strong inhibition was noted at concentrations ≥80%, while minimal or no effect occurred below 30%. MIC and MBC were estimated at around 20%. Statistical analysis confirmed a significant dose-response relationship (ANOVA, p 0.0003), with stronger correlation in MRSA (R=0.84; p<0.001) than P. aeruginosa (R=–0.09; p 0.046). The minimum effective concentration was estimated at 32% for MRSA and 37% for P. aeruginosa. In conclusion, stingless bee propolis demonstrated concentration-dependent antibacterial activity against both Gram-positive (MRSA) and Gram-negative (P. aeruginosa) bacteria in vitro, with increased activity observed at higher concentrations. Minimum effective concentrations were 32% for MRSA and 37% for P. aeruginosa, supporting its potential use in treating infected breast cancer ulcers. These findings highlight propolis as a potential natural alternative for infection control and wound healing.
Keywords: breast cancer; ulcer; stingless bee; propolis; antibacterial effect
References
1. Komite Nasional Penanggulangan Kanker (KPKN). Panduan Nasional Penanganan Kanker: Kanker Payudara [Internet]. 2015. Available from: https://www.poijaya.org/wp-content/uploads/2021/03/PPKPayudara.pdf
2. WHO. Breast Cancer [Internet]. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. Doi: 10.3322/caac.21660
4. Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MC, et al. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368-73. Doi: 10.1128/JCM.01277-13
5. Erwan, Purnamasari DK, Resti R, Muhsinin M. Identifikasi jenis tanaman pakan lebah madu sebagai sumber nektar dan polen. Jurnal Triton. 2022;12(2):206-20. Doi: https://doi.org/10.47687/jt.v13i2.254
6. Kemenkes. Pemahaman Masyarakat akan Penggunaan Obat Masih Rendah [Internet]. 2015. Available from: https://www.kemkes.go.id/id/rilis-kesehatan/pemahaman-masyarakat-akan-penggunaan-obat-masih-rendah
7. Winston KR, French B, Ketch LL. Skin: Anatomy and healing. Plastic Neurosurgery. 2023;24(1):3-37. Doi: 10.1007/978-3-031-27872-3_1
8. Agarwal S, Krishnamurthy K. Histology, Skin. StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537325/
9. Suparna, Ketut, Sari LMKK. Kanker payudara: diagnostik, faktor risiko, dan stadium." Ganesha Medicina 2022;2(1):42-8. Doi: https://doi.org/10.23887/gm.v2i1.47032
10. Sofa, Taufik, Wardiyah A, Rilyani. Faktor risiko kanker payudara pada wanita. Jurnal Penelitian Perawat Profesional. 2023;6(2):493-502. Available from: https://jurnal.globalhealthsciencegroup.com/index.php/ JPPP/article/view/2177
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Christian Manginstar, Marselus Merung, Albert Albert
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
